Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TCMD
STRONG BUYFLAGTactile Systems Technology, Inc. · Healthcare · United States · $620M · Avg Vol: $7M/d
Tactile Systems has strong quality at Q79 with a buyback retiring 3.00% of shares, real corroboration, but value at V44 is below the calibrated floor, so stage one fails. Insider selling is separately adverse.
COMPANY DESCRIPTION
Tactile Systems Technology, Inc. develops and commercializes medical devices for the treatment of chronic conditions such as lymphedema and chronic venous insufficiency. The company's proprietary Flexitouch Plus and other pneumatic compression devices establish a strong market position by offering clinically proven, non-invasive solutions that improve patient outcomes. Tactile Systems operates as a specialized medical technology innovator with a direct-to-patient service model.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 246.8M | 274.4M | 293.0M | 329.5M | 10.1% | 343.5M | 364.8M | 397.6M | 9.8% |
| EPS | -0.89 | 1.24 | 0.71 | 0.83 | -18.2% | 0.86 | 1.09 | 1.50 | 34.5% |
| Shares | 20.3M | 23.6M | 23.9M | 22.4M | +10.8% | 22.6M | — | — | — |
| Debt | 72.2M | 50.4M | 45.1M | 16.0M | -39.5% | 15.2M | — | — | — |
| Equity | 121.4M | 193.6M | 216.6M | 218.9M | 21.7% | — | — | — | — |
| Op CF | 5.2M | 35.9M | 40.7M | 42.8M | 101.8% | 42.1M | — | — | — |
| Inv CF | -1.9M | -2.5M | -2.5M | -2.5M | — | — | — | — | — |
| Fin CF | -9.6M | 5.7M | -4.8M | -51.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TCMD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TCMD | Tactile Systems Technology, Inc.(you) | $620M | 88 | STRONG BUY |
| BVS | Bioventus Inc. | $799M | 96 | STRONG BUY |
| VMD | Viemed Healthcare, Inc. | $451M | 96 | STRONG BUY |
| CNMD | CONMED Corporation | $1.3B | 87 | STRONG BUY |
| ELMD | Electromed, Inc. | $318M | 91 | STRONG BUY |
| DCTH | Delcath Systems, Inc. | $422M | 75 | BUY |
| IRMD | IRADIMED CORPORATION | $1.2B | 79 | BUY |
| AHCO | AdaptHealth Corp. | $1.5B | 80 | STRONG BUY |
| ENOV | Enovis Corporation | $1.6B | 82 | STRONG BUY |
| IART | Integra LifeSciences Holdings Corporation | $1.5B | 79 | BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%